(Q34978630)

English

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

based on heuristic

inferred from title

Ioannis Kyvernitakis

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Volker Ziller

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dana Knöll

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Astrid Storch

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Olaf Hars

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Peyman Hadji

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

0 references

publication date

4 September 2013

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

407

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Practical guidance for the management of aromatase inhibitor-associated bone loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Medication compliance and persistence: terminology and definitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Adherence to tamoxifen over the five-year course

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Acceptance of adjuvant therapy and quality of life issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Assessment of psychological factors associated with adherence to medication regimens among adult patients with asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

Interventions for helping patients to follow prescriptions for medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3844591

8 July 2018

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Adherence with adjuvant hormonal therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Non-adherence to endocrine therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Early discontinuation of tamoxifen: a lesson for oncologists.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-407

21 January 2018

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/24006873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know

1 reference

https://pubmed.ncbi.nlm.nih.gov/24006873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients' understanding of and compliance with medications: the sixth vital sign?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24006873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24006873

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-13-407

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24006873%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34978630&oldid=2197103018"